Preliminary data from the COMPASS-IBD study showed an interdisciplinary care model improved psychosocial outcome values among patients with inflammatory bowel disease. read…
Browsing: Hot headlines in GI
Reported gastrointestinal (GI) outbreaks in England were halved during the first 6 months of the COVID-19 pandemic compared with a…
NEW YORK–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) today announced positive topline results from a Phase 3 study of etrasimod, an…
The North American Society for Pediatric Gastroenterology, Hepatology & Nutrition Fellows Committee, working in close partnership with the NASPGHAN Technology…
Tailored or even generic telephone messages increased colonoscopy for people not up to date on their colorectal cancer (CRC) screening,…
The FDA granted priority review to futibatinib for treatment of certain patients with cholangiocarcinoma. The designation applies to use of…
Raleigh, N.C. – Mar. 29, 2022 – Curi Advisory, Curi’s business unit focused on delivering data-driven business solutions and consulting services…
More than 70% of patients with metastatic colorectal cancer bore financial hardships within the first year of diagnosis despite most…
Irritable bowel syndrome (IBS) had quite a moment in the sun last year when TikTok users turned it into a “hot…
Risk for early-onset colorectal cancer (EOCRC) was not associated with recent antibiotic treatment, according to a study published in Clinical and…